Category

临床试验

MIND Matters | Quarterly Newsletter | Winter 2021

通过 临床试验, 评论, 社区活动, 新冠肺炎, 在新闻中, Longitudinal Cohort, Participants, UCI思想

Message from the Director Happy New Year, Friends of UCI MIND! For many of us, a New Year brings the promise of fresh starts and new beginnings. In 2021, it also means a welcomed good-bye to a very long 2020. Despite the challenges that 2020 brought, it also brought progress that must now continue in 2021. This includes progress in social justice, progress in fighting the COVID-19 pandemic, and progress in research to rid the world of Alzheimer’s disease and related dementias. UCI MIND is committed to contributing to further progress in each of these areas. Though the COVID-19 pandemic…

帖子 MIND Matters | Quarterly Newsletter | Winter 2021 首先出现 UCI思想.

阅读更多

Holidays during COVID-19

通过 临床试验, 评论, 新冠肺炎, Longitudinal Cohort, Participants, UCI思想

Have you noticed the Holiday decorations popping up at shopping malls already? Yes, the Holiday Season is upon us. This year, due to the COVID-19 pandemic, we all need to carefully plan our social gatherings, meals, and guests in our homes. Hopefully, you will find some helpful hints here so you can safely navigate all the Holidays you will celebrate this year.   The very best gift you can give yourself, your loved ones and your friends is to make sure you get your flu vaccine as soon as possible. Keep in mind that grocery stores and malls will be getting…

帖子 Holidays during COVID-19 首先出现 UCI思想.

阅读更多

MIND Matters | Quarterly Newsletter | Fall 2020

通过 临床试验, 评论, 社区活动, 新冠肺炎, 在新闻中, Longitudinal Cohort, Participants, UCI思想

Message from the Director   Dear Friends of UCI MIND, As the COVID-19 pandemic continues to impact our lives this fall, the fight to solve Alzheimer’s disease and related dementias (ADRD) must charge forward. This November, the U.S. FDA will convene an advisory committee to assess potential approval of Biogen’s aducanumab, a monoclonal antibody in development for treatment of early AD. We will watch closely as aducanumab could be the first new approved drug for AD since 2005. Regardless of the outcome of the meeting and subsequent FDA decision – anticipated in March 2021 – this represents a milestone for…

帖子 MIND Matters | Quarterly Newsletter | Fall 2020 首先出现 UCI思想.

阅读更多

Welcome to the UCI Stem Cell Research Center’s Blog!

通过 alzheimer's, CIRM, 临床试验, Dr. Randal Mills, Events, Huntington's disease, OCCCA, Research, Retinitis pigmentosa, Scientists, spinal cord injury, Stem Cell Awareness Day, Stem Cell Research Center, Stem Cells, stroke, UCI

Since this is an inaugural blog, I would like to first introduce myself, Randal Berg, MBA, PhD as the current Chief Administrative Officer (CAO) at the UCI Stem Cell Research Center (SCRC). I am excited to have joined a team … Continue reading

阅读更多
简体中文